-
WASHINGTON — Johnson & Johnson's single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released Wednesday by U.S.…
-
Johnson & Johnson asked U.S. regulators Thursday to clear the world's first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce…
-
Updated 12/18/20, 2:50 p.m.WASHINGTON — The U.S. added a second COVID-19 vaccine to its arsenal Friday, boosting efforts to beat back an outbreak so dire…
-
2nd COVID-19 Vaccine Set For OK In US With Panel EndorsementUpdated 12/17/20, 12:15 p.m.WASHINGTON — A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added…
-
US Allows Emergency COVID-19 Vaccine In Bid To End PandemicWASHINGTON — The U.S. gave the final go-ahead Friday to the nation's first COVID-19 vaccine, marking what could be the beginning of the end of an outbreak…
-
White House Threatens FDA Chief's Job Over Vaccine ApprovalUpdated 12/11/20, 2:46 p.m.WASHINGTON — White House chief of staff Mark Meadows on Friday pressed Food and Drug Administration chief Stephen Hahn to grant…
-
US Panel Endorses Widespread Use Of Pfizer COVID-19 VaccineUpdated 12/10/20, 3:05 p.m.WASHINGTON — A U.S. government advisory panel endorsed widespread use of Pfizer's coronavirus vaccine Thursday, putting the…
-
Pfizer Vaccine Moves Closer To Getting The OK In The USUpdated 12/8/20, 9:48 a.m.WASHINGTON — U.S. regulators Tuesday released their first scientific evaluation of Pfizer's COVID-19 vaccine and confirmed it…
-
U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing…
-
WASHINGTON — The Food and Drug Administration released updated safety standards Tuesday for makers of COVID-19 vaccines after the White House blocked…